{
    "2021-06-11": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Eli Lilly's Internal Probe Clears Its COVID-19 Drug Plant; Memo Says Company Did Not Make False Statements: Reuters",
                "features": {
                    "keywords": [
                        "Lilly",
                        "COVID-19",
                        "Drug Plant",
                        "Internal Probe",
                        "Clears",
                        "False Statements"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Lilly Announces Webcast to Provide Diabetes Portfolio Update at ADA",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Diabetes",
                        "Portfolio Update",
                        "Webcast",
                        "ADA"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Pharma Stock Roundup: FDA Approval for NVO, PFE Products & Other Updates",
                "features": {
                    "keywords": [
                        "FDA",
                        "Approval",
                        "NVO",
                        "PFE",
                        "Products",
                        "Updates"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}